163 related articles for article (PubMed ID: 28482727)
1. Diagnosis of secondary peripheral neurolymphomatosis: a multi-center experience.
Byun JM; Kim KH; Kim M; Kim TM; Jeon YK; Park JH; Paik JH; Lee JM; Lee HY; Lee JS; Heo DS; Lee JO
Leuk Lymphoma; 2017 Nov; 58(11):2624-2632. PubMed ID: 28482727
[TBL] [Abstract][Full Text] [Related]
2.
Tan X; Sun X; Yuan H; He L; Ding C; Jiang L
Hell J Nucl Med; 2022; 25(3):285-296. PubMed ID: 36507885
[TBL] [Abstract][Full Text] [Related]
3. Neurolymphomatosis on 18F-FDG PET/CT: Diagnosis and Therapy Response.
Gykiere P; Jans L; Degrieck B; Goethals I
Clin Nucl Med; 2016 Feb; 41(2):142-3. PubMed ID: 26402124
[TBL] [Abstract][Full Text] [Related]
4. Neurolymphomatosis: a single-center experience of neuromuscular manifestations, treatments, and outcomes.
Jeong J; Kim SW; Sung DH
J Neurol; 2021 Mar; 268(3):851-859. PubMed ID: 33098033
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of FDG-PET in neurolymphomatosis: report of five cases.
Kinoshita H; Yamakado H; Kitano T; Kitamura A; Yamashita H; Miyamoto M; Hitomi T; Okada T; Nakamoto Y; Sawamoto N; Takaori-Kondo A; Takahashi R
J Neurol; 2016 Sep; 263(9):1719-26. PubMed ID: 27286845
[TBL] [Abstract][Full Text] [Related]
6. Secondary Neurolymphomatosis of the Radial Nerve: A Diagnostic Challenge.
Iacobellis F; Di Serafino M; Blasio R; Barbuto L; Pezzullo F; Romano L
Am J Case Rep; 2019 Nov; 20():1652-1658. PubMed ID: 31707401
[TBL] [Abstract][Full Text] [Related]
7. Neurolymphomatosis--diagnosis and assessment of treatment response by FDG PET-CT.
Lin M; Kilanowska J; Taper J; Chu J
Hematol Oncol; 2008 Mar; 26(1):43-5. PubMed ID: 17957824
[TBL] [Abstract][Full Text] [Related]
8. B-cell peripheral neurolymphomatosis: MRI and
DeVries AH; Howe BM; Spinner RJ; Broski SM
Skeletal Radiol; 2019 Jul; 48(7):1043-1050. PubMed ID: 30666391
[TBL] [Abstract][Full Text] [Related]
9. Secondary neurolymphomatosis of spinal nerve roots detected by ¹⁸F-FDG PET/CT: a case report and differential diagnosis of the case.
Wang Y; Wang J; Jiang C; Peng Q; Wu M; Ma X
Hell J Nucl Med; 2015; 18(3):261-3. PubMed ID: 26574697
[TBL] [Abstract][Full Text] [Related]
10. Primary multifocal lymphoma of peripheral nervous system: case report and review of the literature.
Del Grande A; Sabatelli M; Luigetti M; Conte A; Granata G; Rufini V; Del Ciello A; Gaudino S; Fernandez E; Hohaus S; Coli A; Lauriola L
Muscle Nerve; 2014 Dec; 50(6):1016-22. PubMed ID: 25088432
[TBL] [Abstract][Full Text] [Related]
11. Neurolymphomatosis of the peripheral nervous system: a case report and review of the literature.
Sideras PA; Matthews J; Sakib SM; Ofikwu F; Spektor V
Clin Imaging; 2016; 40(6):1253-1256. PubMed ID: 27636384
[TBL] [Abstract][Full Text] [Related]
12. The role of 18F-FDG PET/CT in Neurolymphomatosis: A Comprehensive Imaging Approach.
Usmani S; Jain A; Riyami KA; Ahmed N; Al-Sukaiti R; Shamim MS
J Pak Med Assoc; 2024 Apr; 74(4):822-824. PubMed ID: 38751291
[TBL] [Abstract][Full Text] [Related]
13. Value of
Alobthani G; Romanov V; Isohashi K; Matsunaga K; Watabe T; Kato H; Tatsumi M; Shimosegawa E; Hatazawa J
Hell J Nucl Med; 2018; 21(1):7-14. PubMed ID: 29550841
[TBL] [Abstract][Full Text] [Related]
14. FDG PET-CT evaluation in neurolymphomatosis: imaging characteristics and clinical outcomes.
Davidson T; Kedmi M; Avigdor A; Komisar O; Chikman B; Lidar M; Goshen E; Tzila Zwas S; Ben-Haim S
Leuk Lymphoma; 2018 Feb; 59(2):348-356. PubMed ID: 28750592
[TBL] [Abstract][Full Text] [Related]
15. Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.
Albano D; Patti C; Lagalla R; Midiri M; Galia M
J Magn Reson Imaging; 2017 Apr; 45(4):1082-1089. PubMed ID: 27603267
[TBL] [Abstract][Full Text] [Related]
16. The incidence of secondary central nervous system involvement in patients with non-Hodgkin's lymphoma as detected by 18F-FDG PET/CT.
Akkas BE; Vural GU
Nucl Med Commun; 2013 Jan; 34(1):50-6. PubMed ID: 23111376
[TBL] [Abstract][Full Text] [Related]
17. Neurolymphomatosis: MRI and (18) FDG-PET features.
Lim AT; Clucas D; Khoo C; Parameswaran BK; Lau E
J Med Imaging Radiat Oncol; 2016 Feb; 60(1):92-5. PubMed ID: 25974748
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of 18F-FDG PET/CT in the detection of neurolymphomatosis.
Zhou WL; Wu HB; Weng CS; Han YJ; Wang M; Huang S; Wang QS
Nucl Med Commun; 2014 Nov; 35(11):1107-11. PubMed ID: 25144562
[TBL] [Abstract][Full Text] [Related]
19. [Neurolymphomatosis due to enteropathy-associated T-cell lymphoma clinically diagnosed by FDG-PET/CT and subsequently confirmed by autopsy].
Uematsu N; Sumi M; Kaiume H; Takeda W; Kirihara T; Ueki T; Hiroshima Y; Ueno M; Ichikawa N; Watanabe M; Kobayashi H
Rinsho Ketsueki; 2018; 59(1):69-74. PubMed ID: 29415941
[TBL] [Abstract][Full Text] [Related]
20. Neurolymphomatosis: a case series of clinical manifestations, treatments, and outcomes.
Kamiya-Matsuoka C; Shroff S; Gildersleeve K; Hormozdi B; Manning JT; Woodman KH
J Neurol Sci; 2014 Aug; 343(1-2):144-8. PubMed ID: 24928074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]